[Video] Rare Disease Day: What’s Your Why
Hear from the Orsini team on our “why” and what drives us to provide exceptional care for patients and families impacted by a rare disease:
Orsini is the exclusive specialty pharmacy provider for MIPLYFFA™ (arimoclomol), the first FDA-approved treatment for Niemann-Pick disease type C. Learn more →